CIARDULLO, CARMELA
 Distribuzione geografica
Continente #
NA - Nord America 386
EU - Europa 370
AS - Asia 122
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 883
Nazione #
US - Stati Uniti d'America 381
IE - Irlanda 103
DE - Germania 81
SE - Svezia 63
SG - Singapore 48
UA - Ucraina 34
HK - Hong Kong 28
IT - Italia 27
CN - Cina 24
FI - Finlandia 23
RU - Federazione Russa 20
IN - India 19
GB - Regno Unito 13
CA - Canada 5
EU - Europa 3
BE - Belgio 2
CL - Cile 2
IR - Iran 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
ES - Italia 1
GR - Grecia 1
LT - Lituania 1
Totale 883
Città #
Dublin 103
Jacksonville 69
Dearborn 40
Wilmington 40
Chandler 33
Hong Kong 28
Ann Arbor 17
Lawrence 12
Princeton 12
Boardman 11
San Mateo 11
Ashburn 10
Beijing 9
Bremen 9
Düsseldorf 8
Moscow 8
Piemonte 8
Singapore 8
Andover 6
Cagliari 4
Florence 4
Toronto 4
Grafing 3
Hefei 3
Nanjing 3
Bangalore 2
Brussels 2
Fuzhou 2
Helsinki 2
Kunming 2
Noicattaro 2
San Francisco 2
Woodbridge 2
Zanjan 2
Berlin 1
Bologna 1
Denia 1
Des Moines 1
Fairfield 1
Falkenstein 1
Guangzhou 1
Gunzenhausen 1
Kemerovo 1
Leawood 1
Leipzig 1
London 1
Nanchang 1
Norwalk 1
Nuremberg 1
Ottawa 1
Sacramento 1
Seattle 1
Taiyuan 1
Treviso 1
Wuhan 1
Totale 502
Nome #
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 120
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 82
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 79
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 78
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 77
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 74
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 73
MOLECULAR BASES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN LIGHT OF NEW TREATMENTS 70
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 70
Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance. 69
GENETIC ABERRATIONS OF SIGNALING PATHWAYS IN LYMPHOMAGENESIS: REVELATIONS FROM NEXT GENERATION SEQUENCING STUDIES 63
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia 55
Totale 910
Categoria #
all - tutte 4.894
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.894


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202046 0 0 0 0 0 0 0 0 0 34 12 0
2020/202181 15 2 12 0 13 0 12 1 13 0 13 0
2021/2022114 2 2 16 10 11 0 8 3 14 11 11 26
2022/2023246 13 10 24 4 18 27 8 11 111 0 13 7
2023/202497 10 10 6 2 12 0 14 10 0 0 3 30
2024/2025101 3 1 3 1 13 10 6 10 28 26 0 0
Totale 910